Compliance review: Sun Pharma’s Halol plant gets 8 USFDA...

Dununu.com Dununu

Sponsor

Compliance review: Sun Pharma’s Halol plant gets 8 USFDA observations; company vows remedial steps after inspection

RSS Feed Business

Posted

118

Sun Pharmaceutical Industries faces scrutiny. The USFDA issued a Form 483. This follows an inspection of its Halol manufacturing plant in Gujarat. The inspection occurred between June 2 and June 13, 2025. Eight observations were noted regarding Good Manufacturing Practices. Sun Pharma is expected to respond. They will submit a remediation plan to address the concerns.

Read Full Article

Please log in to like, share and comment!

Maoist leaders seek to reconcile with Biplav after his move to form separate front

KATHMANDU: The much-anticipated unification process between the CPN (Maoist Centre) and the Netra...

By 0 23

UML to focus on four key agendas at upcoming statute convention

KATHMANDU: The ruling CPN (UML) is set to deliberate on four major agendas during its second...

By 0 50

Adrienne Davis' playful warning lights up social media as Max Johnson grinds through UNC camp

Adrienne Davis, girlfriend of UNC quarterback Max Johnson, playfully warned friends against...

By 0 53

120 Bahadur: Karan Johar hails Farhan Akhtar’s teaser

Filmmaker Karan Johar praised Farhan Akhtar’s war film '120 Bahadur' teaser as...

By 0 56

US visa delays push international students to UK, Asia, and Middle East

By 0 59